Pharmaceutical portfolio planning and management is an integral part of the drug development process. Strategic decision-making is critical when determining which drugs to prioritize for development. In this article, Xtalks spoke with Dr. Wendy Cheung, Global Head of Oncology Strategy New Product Planning and Operations Specialty Care at Sanofi Genzyme to gain insights into the key considerations and current challenges in achieving a successful product launch.
TORONTO, June 16, 2023 /PRNewswire-PRWeb/ -- Portfolio planning and management is an integral part of the drug development process. Strategic decision-making is critical when determining which drugs to prioritize for development, and for building a robust pipeline for a specific indication or class of drugs. These decisions are key in the path to commercial success and most importantly, getting effective treatments to patients.
Only ten to 20 percent of drugs that make it through the development process end up getting approved and this has remained unchanged for the past several decades. While the COVID-19 pandemic helped the industry and regulatory bodies recognize how drug development can be effectively accelerated, there is still a lot of work to do in achieving better drug approval timelines and rates of success.
Portfolio planning involves several steps, which include the assessment of unmet needs in the space, prioritization, portfolio analysis and risk assessment among others. Many of these steps require continued strategic planning and decision-making throughout the development life cycle of a product and/or portfolio.
In this article, Xtalks spoke with Dr. Wendy Cheung, a leader in the strategy and product planning space, to gain insights into pharmaceutical portfolio planning. Dr. Cheung is the Global Head of Oncology Strategy New Product Planning and Operations Specialty Care at Sanofi Genzyme.
Dr. Cheung shared some of the current considerations and challenges in portfolio planning and how they can be tackled. She also described the keys to a successful portfolio and product launch, which include strategic decision-making and engaging different stakeholders early in the process, from investigators and regulatory bodies to patients, caregivers and advocacy groups. Dr. Cheung also discussed her journey as a leader in the product planning space as well as tips and advice for emerging leaders.
For more information and to read the full article featuring Dr. Wendy Cheung, visit: Pharmaceutical Portfolio Planning in Today's Drug Development Climate.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Ayesha Rashid
Tel: +1 (416) 977-6555 x272
Email: [email protected]
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, arashid@xtalks.com
SOURCE Xtalks
Share this article